- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Syntara Ltd (SNT)
Syntara Ltd stock price live, this page displays ASX SNT stock exchange data. View the SNT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Syntara Ltd real time stock price chart below.
What Is the Syntara Ltd Stock Price Today?
The Syntara Ltd stock price today is 0.035.
What Is the Stock Symbol for Syntara Ltd?
The stock symbol for Syntara Ltd is "SNT."
What Stock Exchange Does Syntara Ltd Trade On?
Syntara Ltd is listed and trades on the Sydney stock exchange.
Is Syntara Ltd a Good Stock to Buy?
Determining whether Syntara Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SNT quote. (ISIN: AU0000312480)
What Is the Syntara Ltd Stock Price Today?
The Syntara Ltd stock price today is 0.035.
What Is the Stock Symbol for Syntara Ltd?
The stock symbol for Syntara Ltd is "SNT."
What Stock Exchange Does Syntara Ltd Trade On?
Syntara Ltd is listed and trades on the Sydney stock exchange.
Is Syntara Ltd a Good Stock to Buy?
Determining whether Syntara Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SNT quote. (ISIN: AU0000312480)
Sydney
Currency in AUD
0.035
+0.001(+2.94%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.033
0.035
52 wk Range
0.023
0.095
SNT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0330.035
52 wk Range
0.0230.095
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SNT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
0.125
Upside
+257.14%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Syntara Ltd Company Profile
Syntara Limited operates as a clinical-stage drug development company that targets extracellular matrix dysfunction through amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis in Australia. Its lead product candidate, amsulostat, is being developed for the treatment of bone marrow cancer myelofibrosis and is in Phase 1c/2 studies for patients with myelodysplastic syndrome. The company also develops topical pan-LOX inhibitors with SNT-9465, which is in a Phase 1a/b study for hypertrophic scars; SNT-6302 for keloid scars; and SNT-4728 to treat sleep disorders and slow progression of neurodegenerative diseases by reducing neuroinflammation. In addition, it develops other drug candidates that target fibrotic and inflammatory diseases, including kidney fibrosis, MASH, pulmonary fibrosis, and cardiac fibrosis. The company was formerly known as Pharmaxis Ltd and changed its name to Syntara Limited in December 2023. Syntara Limited was incorporated in 1998 and is headquartered in Frenchs Forest, Australia.
Syntara Ltd Earnings Call Summary for Q3/2025
- Syntara reported $18M cash balance, providing 18-month runway; stock up 3.57% to $3.42 amid investor optimism
- Lead drug 5505 targets myelofibrosis market valued at $1.9B; company exploring partnerships for clinical studies
- Key data presentation expected at European Hematology Association meeting in June; FDA guidance anticipated by Q3
- Revenue growth of 9.03% in last 12 months; stock near 52-week high of $3.97 with 144.29% return over past year
- Potential risks include delays in MDS trial initiation, critical FDA outcomes, and competitive pressure from JAK inhibitors
Last Updated: 05/01/2025, 10:14 AM
Read Full TranscriptCompare SNT to Peers and Sector
Metrics to compare | SNT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSNTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.7x | −9.7x | −0.6x | |
PEG Ratio | −0.07 | −0.06 | 0.00 | |
Price/Book | 3.6x | 7.0x | 2.6x | |
Price / LTM Sales | 7.8x | 31.6x | 3.2x | |
Upside (Analyst Target) | 257.1% | 118.9% | 42.7% | |
Fair Value Upside | Unlock | −4.2% | 6.8% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.125
(+257.14% Upside)
Earnings
Latest Release
Nov 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
FAQ
What Is the Syntara (SNT) Stock Price Today?
The Syntara stock price today is 0.035
What Stock Exchange Does Syntara Trade On?
Syntara is listed and trades on the Sydney Stock Exchange stock exchange.
What Is the Stock Symbol for Syntara?
The stock symbol for Syntara is "SNT."
What Is the Syntara Market Cap?
As of today, Syntara market cap is 57.13M.
What Is Syntara's Earnings Per Share (TTM)?
The Syntara EPS (TTM) is -0.01.
When Is the Next Syntara Earnings Date?
Syntara will release its next earnings report on Feb 05, 2026.
From a Technical Analysis Perspective, Is SNT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Syntara Stock Split?
Syntara has split 1 times.
How Many Employees Does Syntara Have?
Syntara has 21 employees.
What is the current trading status of Syntara (SNT)?
As of Jan 01, 2026, Syntara (SNT) is trading at a price of 0.035, with a previous close of 0.034. The stock has fluctuated within a day range of 0.033 to 0.035, while its 52-week range spans from 0.023 to 0.095.
What Is Syntara (SNT) Price Target According to Analysts?
The average 12-month price target for Syntara is AUD0.125, with a high estimate of AUD0.19 and a low estimate of AUD0.06. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +257.14% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.